PubMed HealthSearch

PubMed · 6410702

Nutrients and ventilation.

Abstract

Nutritional support of the patient with respiratory failure may play a key role in recovery. Nutritional intake not only indirectly influences lung function by altering body composition and most defense mechanisms but interacts directly with respiratory function in a variety of ways. This review will focus on 2 such interactions; the effect of glucose on CO2 production and the effect of protein on ventilatory drive. Glucose administration results in increases in CO2 production via 2 mechanisms; 1) a thermogenic effect and 2) an increase in the respiratory quotient (RQ). In the hypermetabolic, acutely ill patient, both the thermogenic effect and the rise in the RQ contribute to the rise in CO2 production. In the malnourished patient, a rise in the RQ is the primary mechanism for the increase. In either case, the increased need for CO2 elimination results in an increase in ventilatory demand which may precipitate respiratory distress in a patient with previously compromised pulmonary function. Infusions of amino acids, either alone or as a part of a complete nutritional support regimen, results in an enhanced ventilatory response to CO2. This seems to be a result of the thermogenic effect of protein and an increase in the ratio of the plasma concentration of the large amino acids to tryptophan. We postulate that brain uptake of tryptophan which is a precursor to serotonin (a known respiratory inhibitor) is reduced by the presence of increased amounts of the large neutral amino acids that compete with tryptophan for transport across the blood brain barrier, thereby resulting in respiratory stimulation.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J Askanazi, C Weissman, P A LaSala, P M Charlesworth. 1983. Nutrients and ventilation.. https://pubmed.ncbi.nlm.nih.gov/6410702/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Chimeric structural isomer fragments as cost-efficient internal standards for amino acid quantification by mass spectrometry.

Amino acid (AA) profiles from body fluids such as blood and urine are clinical indicators for diagnosing metabolic and hepatic diseases. Current quantitative methods, such as liquid chromatography-mass spectrometry (LC-MS) with isotopically labelled internal standards (ISs), are costly and technically demanding. This study proposes a cost-efficient alternative using structural isomers as ISs in a direct liquid infusion (DLI) tandem mass spectrometry (MS/MS) approach. The method leverages chimeric spectra and fragment intensity ratios to quantify AAs, demonstrating high linearity and precision even with a 3D ion trap mass analyser. This approach offers a viable strategy for AA quantification in preventive medicine, particularly for screening metabolic diseases such as phenylketonuria, diabetes, and liver dysfunction.

Amino Acids

AAindex: Amino Acid Index Database.

AAindex is a database of numerical indices representing various physicochemical and biochemical properties of amino acids and pairs of amino acids. It consists of two sections: AAindex1 for the amino acid index of 20 numerical values and AAindex2 for the amino acid mutation matrix of 210 numerical values. Each entry of either AAindex1 or AAindex2 consists of the definition, the reference information, a list of related entries in terms of the correlation coefficient, and the actual data. The database may be accessed through the DBGET/LinkDB system at GenomeNet (http://www.genome.ad. jp/dbget/) or may be downloaded by anonymous FTP (ftp://ftp.genome. ad.jp/db/genomenet/aaindex/).

Amino Acids

Effects of add-back therapy on bone mineral density and pyridinium crosslinks in patients with endometriosis treated with gonadotropin-releasing hormone agonists.

Treatment of endometriosis with gonadotropin-releasing hormone agonists (GnRHa) is limited to 6 months because of possible adverse effects on bone metabolism. We designed a randomized, double-blind, placebo-controlled, prospective study of 27 patients with endometriosis who were given GnRHa with or without hormone add-back therapy (+ 20 microg of ethinyl estradiol with 0.15 mg desogestrel) designed to suppress the adverse effects of hypoestrogenism while preserving the efficacy of GnRHa. Both regimens showed significant improvements in endometriosis, dysmenorrhea, and pelvic pain; effects were significantly better in the GnRHa + placebo group. The GnRHa + placebo group had significantly higher serum calcium levels and a significantly higher loss of lumbar spine bone mineral density (BMD). Urinary levels of pyridinium crosslinks increased significantly in the GnRHa + placebo group, and declined to normal in the GnRHa + add-back group. The add-back therapy protects women taking GnRHas from severe loss of BMD and accelerated bone collagen resorption, but reduces the efficacy of the GnRHa.

Amino Acids